Literature DB >> 11322830

Tumor invasion as dysregulated cell motility.

J Kassis1, D A Lauffenburger, T Turner, A Wells.   

Abstract

Investigations across a range of disciplines over the past decade have brought the study of cell motility and its role in invasion to an exciting threshold. The biophysical forces proximally involved in generating cell locomotion, as well as the underlying signaling and genomic regulatory processes, are gradually becoming elucidated. We now appreciate the intricacies of the many cellular and extracellular events that modulate cell migration. This has enabled the demonstration of a causal role of cell motility in tumor progression, with various points of 'dysregulation' of motility being responsible for promoting invasion. In this paper, we describe key fundamental principles governing cell motility and branch out to describe the essence of the data that describe these principles. It has become evident that many proposed models may indeed be converging into a tightly-woven tapestry of coordinated events which employ various growth factors and their receptors, adhesion receptors (integrins), downstream molecules, cytoskeletal components, and altered genomic regulation to accomplish cell motility. Tumor invasion occurs in response to dysregulation of many of these modulatory points; specific examples include increased signaling from the EGF receptor and through PLC gamma, altered localization and expression of integrins, changes in actin modifying proteins and increased transcription from specific promoter sites. This diversity of alterations all leading to tumor invasion point to the difficulty of correcting causal events leading to tumor invasion and rather suggest that the underlying common processes required for motility be targeted for therapeutic intervention. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11322830     DOI: 10.1006/scbi.2000.0362

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  40 in total

Review 1.  Integrins in invasive growth.

Authors:  Cord Brakebusch; Daniel Bouvard; Fabio Stanchi; Takao Sakai; Reinhard Fässler
Journal:  J Clin Invest       Date:  2002-04       Impact factor: 14.808

2.  Directional persistence of EGF-induced cell migration is associated with stabilization of lamellipodial protrusions.

Authors:  Brian D Harms; Gina M Bassi; Alan Rick Horwitz; Douglas A Lauffenburger
Journal:  Biophys J       Date:  2005-02       Impact factor: 4.033

3.  Gelsolin-induced epithelial cell invasion is dependent on Ras-Rac signaling.

Authors:  Veerle De Corte; Erik Bruyneel; Ciska Boucherie; Marc Mareel; Joël Vandekerckhove; Jan Gettemans
Journal:  EMBO J       Date:  2002-12-16       Impact factor: 11.598

4.  Mechanosensitive Ca(2+) permeant cation channels in human prostate tumor cells.

Authors:  Rosario Maroto; Alexander Kurosky; Owen P Hamill
Journal:  Channels (Austin)       Date:  2012-07-01       Impact factor: 2.581

5.  Screening for motility-associated genes in malignant astrocytoma cell lines.

Authors:  Hyang-Hwa Ryu; Shin Jung; Heung-Suk Sun; Tae-Young Jung; Shu-Guang Jin; Yong-Hao Jin; In-Young Kim; Young-Il Jeong; Sam-Suk Kang
Journal:  J Neurooncol       Date:  2006-10-18       Impact factor: 4.130

6.  Hepatic nonparenchymal cells drive metastatic breast cancer outgrowth and partial epithelial to mesenchymal transition.

Authors:  Donald P Taylor; Amanda Clark; Sarah Wheeler; Alan Wells
Journal:  Breast Cancer Res Treat       Date:  2014-03-09       Impact factor: 4.872

7.  AMPA receptors promote perivascular glioma invasion via beta1 integrin-dependent adhesion to the extracellular matrix.

Authors:  Yuji Piao; Li Lu; John de Groot
Journal:  Neuro Oncol       Date:  2008-10-28       Impact factor: 12.300

8.  BCL2 inhibits cell adhesion, spreading, and motility by enhancing actin polymerization.

Authors:  Hengning Ke; Vandy I Parron; Jeff Reece; Jennifer Y Zhang; Steven K Akiyama; John E French
Journal:  Cell Res       Date:  2010-02-09       Impact factor: 25.617

9.  The emerging role of nimotuzumab in the treatment of non-small cell lung cancer.

Authors:  William Boland; Gwyn Bebb
Journal:  Biologics       Date:  2010-11-09

10.  Loss-of-function screening by randomized intracellular antibodies: identification of hnRNP-K as a potential target for metastasis.

Authors:  Atsushi Inoue; Shinya Y Sawata; Kazunari Taira; Renu Wadhwa
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-04       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.